When it comes to diseases or ailments, symptoms can often overlap and could either mean something serious or something that is very much benign. The same could be said for diseases like cancer in whichever part of the body that has a tumor.
In terms of lung cancer, there is another symptom that should be noted that could be a sign of the presence of the disease in a person. Express reports that drooping eyes could be such a symptom. Lung cancer is one of the diseases that affect a lot of people in the United Kingdom, and though there is no cure for it yet, it is important to recognize the symptoms and make a visit to the doctor as soon as possible if the signs develop or get worse over time.
It is reported that some kinds of lung cancer can bring about Horner’s Syndrome, or more commonly known as drooping eyes. According to the American Cancer Society, some tumors in the lungs, the upper part specifically, are referred to as Pancoast tumors and are more likely “non-small cell lung cancer.”
This kind of tumor affects some nerves of the eye and a part of the face. One symptom of Horner’s Syndrome is one eyelid drooping or the weakness of one eyelid. Another symptom found in the eye is a smaller pupil.
While there is no exact cause when it comes to lung cancer, there are factors that could determine whether a person has a big risk of developing the disease or not. There are factors beyond a person’s control which could put them at a risk, but lifestyle plays a big part in it as well. The most popular known factor is smoking, and heavy smokers have a higher risk of developing this cancer. However, it can be controlled by quitting the habit.
Simply put, the more you smoke, the more you are at risk for lung cancer.
But unfortunately, even non-smokers can develop lung cancer, popularly through inhaling the secondhand smoke coming from smokers. Other factors would be exposure to other carcinogens and asbestos as well as radon gas.


FDA Investigates New Cyclospora Outbreak as U.S. Cases Continue to Rise
Alcohol is one of the most dangerous drugs, yet its presence is ubiquitous in social settings and celebrations
Novartis M&A Strategy Faces Investor Scrutiny After Drug Setbacks
Hanmi Pharm Soars 30% on $2.3 Billion Genentech Obesity Drug Deal
U.S. Issues Cuba Health Alert as Illnesses Rise
US-Backed Pediatric HIV Treatment Drops After Foreign Aid Changes, Study Finds
Eli Lilly Eyes AtaiBeckley Acquisition to Expand Psychedelic Mental Health Pipeline
Moderna Short Sellers Hit With $4.8 Billion Loss as Stock Soars
Novo Nordisk Raises 2025 Outlook Despite Wegovy Pill Miss and CagriSema Setback
Trump Administration Bars U.S. Travelers From Congo Flights Amid Ebola Outbreak
3 clinical-grade skincare creams you really shouldn’t buy online
Novo Nordisk Eyes Turnaround as Oral Wegovy Challenges Eli Lilly in Weight-Loss Drug Race
AstraZeneca, Bristol Myers Squibb Explore Mega Merger Worth Nearly $400 Billion
France Keeps Top Health Alert as Officials Brace for Another Heatwave
GLP-1 Weight-Loss Drug Use Surges Among U.S. Children 



